Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury

被引:343
作者
Iwakura, A [1 ]
Luedemann, C [1 ]
Shastry, S [1 ]
Hanley, A [1 ]
Kearney, M [1 ]
Aikawa, R [1 ]
Isner, JM [1 ]
Asahara, T [1 ]
Losordo, DW [1 ]
机构
[1] Tufts Univ, Sch Med, St Elizabeths Med Ctr, Div Cardiovasc Res, Boston, MA 02135 USA
关键词
estrogen; endothelium; arteries; nitric oxide synthase;
D O I
10.1161/01.CIR.0000106906.56972.83
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - We hypothesized that estrogen-induced acceleration of reendothelialization might be mediated in part by effects involving mobilization and incorporation of bone marrow - derived endothelial progenitor cells (EPCs). Methods and Results - Carotid injury was induced in ovariectomized wild-type mice receiving either 17beta-estradiol or placebo. Estradiol treatment significantly accelerated reendothelialization of injured arterial segments within 7 days and resulted in a significant reduction of medial thickness 14 and 21 days after the injury. Significant increases in circulating EPCs 3 days after the injury were observed in the estradiol group compared with placebo-treated mice. These data were further supported by fluorescence-activated cell sorting analysis, which disclosed a significant increase in Sca-1/Flk1 - positive cells in estradiol versus control mice. To evaluate the effects of estradiol on bone marrow - derived EPC incorporation at sites of reendothelialization, carotid injury was established in ovariectomized wild-type mice transplanted with bone marrow from transgenic donors expressing beta-galactosidase transcriptionally regulated by the Tie-2 promoter. Significantly greater numbers of X-gal - positive cells were observed at reendothelialized areas in the estradiol group 3 days after injury as compared with placebo. Fluorescent immunohistochemistry 14 days after the injury documented a marked increase in cells expressing both beta-gal, indicating bone marrow origin and Tie-2 expression, and isolectin B4, also indicating endothelial lineage, in the estradiol group compared with control. In contrast, estradiol did not accelerate reendothelialization or augment EPC mobilization into the peripheral circulation after injury in endothelial nitric oxide synthase - deficient mice (eNOS(-/-)). Furthermore, estradiol exhibited direct stimulatory effects on EPC mitogenic and migration activity and inhibited EPC apoptosis. Conclusions - Estradiol accelerates reendothelialization and attenuates medial thickening after carotid injury in part by augmenting mobilization and proliferation of bone marrow - derived EPCs and their incorporation into the recovering endothelium at the site of injury.
引用
收藏
页码:3115 / 3121
页数:7
相关论文
共 34 条
  • [1] Aikawa R, 2000, CIRCULATION, V102, P2873
  • [2] LOCAL-DELIVERY OF VASCULAR ENDOTHELIAL GROWTH-FACTOR ACCELERATES REENDOTHELIALIZATION AND ATTENUATES INTIMAL HYPERPLASIA IN BALLOON-INJURED RAT CAROTID-ARTERY
    ASAHARA, T
    BAUTERS, C
    PASTORE, C
    KEARNEY, M
    ROSSOW, S
    BUNTING, S
    FERRARA, N
    SYMES, JF
    ISNER, JM
    [J]. CIRCULATION, 1995, 91 (11) : 2793 - 2801
  • [3] Isolation of putative progenitor endothelial cells for angiogenesis
    Asahara, T
    Murohara, T
    Sullivan, A
    Silver, M
    vanderZee, R
    Li, T
    Witzenbichler, B
    Schatteman, G
    Isner, JM
    [J]. SCIENCE, 1997, 275 (5302) : 964 - 967
  • [4] Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization
    Asahara, T
    Masuda, H
    Takahashi, T
    Kalka, C
    Pastore, C
    Silver, M
    Kearne, M
    Magner, M
    Isner, JM
    [J]. CIRCULATION RESEARCH, 1999, 85 (03) : 221 - 228
  • [5] VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells
    Asahara, T
    Takahashi, T
    Masuda, H
    Kalka, C
    Chen, DH
    Iwaguro, H
    Inai, Y
    Silver, M
    Isner, JM
    [J]. EMBO JOURNAL, 1999, 18 (14) : 3964 - 3972
  • [6] Brouchet L, 2001, CIRCULATION, V103, P423
  • [7] BURGER HG, 2001, ENDOCRINOLOGY
  • [8] CLOWES AW, 1978, LAB INVEST, V39, P141
  • [9] CLOWES AW, 1983, LAB INVEST, V49, P327
  • [10] HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway
    Dimmeler, S
    Aicher, A
    Vasa, M
    Mildner-Rihm, C
    Adler, K
    Tiemann, M
    Rütten, H
    Fichtlscherer, S
    Martin, H
    Zeiher, AM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (03) : 391 - 397